Prof. Dr. · Tıp Fakültesi Dekanlığı
Genel bakış
After completing my Ph.D. on nicotine addiction under Ian P. Stolerman at the Institute of Psychiatry, King’s College London, I embarked on a career dedicated to advancing the science of nicotine dependence. My early postdoctoral work at the Max-Planck Institute for Psychiatry in Munich produced influential publications, followed by a prolific period at the Addiction Research Center in Baltimore, where I collaborated with Steve Goldberg on nicotine self-administration studies. In recognition of this work, I received the SRNT Outstanding Young Investigator Paper Session Award in 1996. Throughout my career, my research has focused on the neurobiological determinants of nicotine dependence, with a particular emphasis on developing translational models to evaluate the clinical efficacy of smoking cessation agents while working as a senior lecturer at Newcastle University, UK. This programme of work has contributed to a deeper understanding of addiction mechanisms and informed strategies for therapeutic intervention, reinforcing my commitment to bridging laboratory science with clinical application.<o:p></o:p>
This is work in progress. Will update this site, once projects are funded.
Pharmacology & Pharmacy · Substance Abuse
Eğitim ve Yetkinlikler
2 kayıt
University of London-Kings College London
University of Sunderland
Mesleki Deneyim
4 kayıt
Atatürk Üniversitesi Tıp Fakültesi Dekanlığı
University of Hertfordshire
Newcastle University
University of London-Kings College London
Yayınlar
15 kayıt
Selective Effects of Acutely Administered N-Acetyl-Cysteine in Rodent Models of Nicotine-Conditioned Behaviours
Kelsey Stoddart, Michael Davies, Jamie Oughton, Emma Malcolm, Shakir D. AlSharari, Mohammed Shoaıb
Addiction Biology, Cilt 30, Sayı 9 · DOI: 10.1111/adb.70051- WoS Q2
- Scopus Q1
- PlumX
Pentylenetetrazol-like stimulus is not produced following naloxone-precipitated mitragynine withdrawal in rats.
Illa S Johari, Norsyifa Harun, Zarif M Sofian, Mohammed Shoaıb
Psychopharmacology, Cilt 238, Sayı 11, ss. 3183–3191 · DOI: 10.1007/s00213-021-05934-4- WoS Q2
- Scopus Q1
- WoS 8 atıf
- PlumX
Assessing physiological dependence and withdrawal potential of mitragynine using schedule-controlled behaviour in rats.
Norsyifa Harun, Illa Syafiqah Johari, Sharif Mahsufi Mansor, Mohammed Shoaıb
Psychopharmacology, Cilt 237, Sayı 3, ss. 855–867 · DOI: 10.1007/s00213-019-05418-6- WoS Q2
- Scopus Q2
- WoS 30 atıf
- PlumX
Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
E Malcolm, F I Carroll, B Blough, M I Damaj, Mohammed Shoaıb
Psychopharmacology, Cilt 232, Sayı 15, s. 2763 · DOI: 10.1007/s00213-015-3908-z- WoS Q1
- Scopus Q1
- WoS 8 atıf
- PlumX
Discriminative stimulus properties of mitragynine (kratom) in rats.
Norsyifa Harun, Zurina Hassan, Visweswaran Navaratnam, Sharif M Mansor, Mohammed Shoaıb
Psychopharmacology, Cilt 232, Sayı 13, s. 2227 · DOI: 10.1007/s00213-015-3866-5- WoS Q1
- Scopus Q1
- WoS 63 atıf
- PlumX
Concurrent access to nicotine and sucrose in rats.
Leigh V Panlilio, Lee Hogarth, Mohammed Shoaıb
Psychopharmacology, Cilt 232, Sayı 8, s. 1451 · DOI: 10.1007/s00213-014-3787-8- WoS Q1
- Scopus Q1
- WoS 25 atıf
- PlumX
Translating the smoking cessation properties of the antidepressant nortriptyline using reinforcing, discriminative and aversive stimulus effects of nicotine in rats.
Victoria C Wing, Mohammed Shoaıb
Psychopharmacology, Cilt 219, Sayı 3, s. 847 · DOI: 10.1007/s00213-011-2413-2- WoS Q1
- Scopus Q1
- WoS 5 atıf
- PlumX
Neuroanatomical targets of reboxetine and bupropion as revealed by pharmacological magnetic resonance imaging.
Sakthivel Sekar, J Van Audekerke, G Vanhoutte, A S Lowe, A M Blamire, A Van der Linden, T Steckler, Mohammed Shoaıb, Marleen Verhoye
Psychopharmacology, Cilt 217, Sayı 4, s. 549 · DOI: 10.1007/s00213-011-2311-7- WoS Q1
- Scopus Q1
- WoS 6 atıf
- PlumX
Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement.
Britta Hahn, Mohammed Shoaıb, Ian P Stolerman
Psychopharmacology, Cilt 217, Sayı 1, ss. 75–82 · DOI: 10.1007/s00213-011-2258-8- WoS Q1
- Scopus Q1
- WoS 48 atıf
- PlumX
Neuroadaptive responses to citalopram in rats using pharmacological magnetic resonance imaging.
Sakthivel Sekar, M Verhoye, J Van Audekerke, G Vanhoutte, Andrew S Lowe, Andrew M Blamire, Thomas Steckler, A Van der Linden, Mohammed Shoaıb
Psychopharmacology, Cilt 213, Sayı 2-3, s. 521 · DOI: 10.1007/s00213-010-2084-4- WoS Q1
- Scopus Q1
- WoS 19 atıf
- PlumX
Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats.
Naila Ismayilova, Mohammed Shoaıb
Psychopharmacology, Cilt 210, Sayı 2, s. 211 · DOI: 10.1007/s00213-010-1845-4- WoS Q1
- Scopus Q1
- WoS 32 atıf
- PlumX
Contextual stimuli modulate extinction and reinstatement in rodents self-administering intravenous nicotine.
Victoria C Wing, Mohammed Shoaıb
Psychopharmacology, Cilt 200, Sayı 3, s. 357 · DOI: 10.1007/s00213-008-1211-y- WoS Q1
- Scopus Q1
- WoS 38 atıf
- PlumX
Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
V C Wing, Mohammed Shoaıb
Psychopharmacology, Cilt 195, Sayı 3, s. 303 · DOI: 10.1007/s00213-007-0902-0- WoS Q1
- Scopus Q1
- WoS 22 atıf
- PlumX
Effects of isoarecolone, a nicotinic receptor agonist in rodent models of nicotine dependence.
Mohammed Shoaıb
Psychopharmacology, Cilt 188, Sayı 2, s. 252 · DOI: 10.1007/s00213-006-0498-9- WoS Q1
- Scopus Q1
- WoS 19 atıf
- PlumX
Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats.
Mohammed Shoaıb, I P Stolerman
Psychopharmacology, Cilt 143, Sayı 3, s. 318 · DOI: 10.1007/s002130050954- WoS Q1
- Scopus Q1
- WoS 77 atıf
- PlumX
Bilimsel & Mesleki Faaliyetler
1 kayıt
-
2026 – Devam ediyor
Federasyon · Uluslararası Federation of European Neurosciences
Asli Üye · Belçika